SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Mazda Motor Corp (OTCMKTS:MZDAY) has issued on Wednesday the Japanese version of the Mazda Sustainability Report 2016, and the Japanese and English versions of the Annual Report 2016. The English version of the former, which highlights the company’s corporate social responsibility (CSR) initiatives and feats for the recently concluded fiscal year (FY) 2016, will be released next month. Meanwhile, the latter outlines financial and corporate updates.

Mazda Sustainability Report 2016

Masamichi Kogai, Mazda Motor CEO, President, and Representative Director, noted that the company aims to make future cars more sustainable and eco-friendly while optimizing performance. The carmaker also intends to improve brand value, bringing customers a better experience.

Annual Report 2016

In the Annual Report 2016, Kogai reiterated the company’s achievements, specifically with the Structural Reform Plan, as well as the aspects of the upcoming Structural Reform Stage 2.

Meanwhile, Akira Marumoto, Mazda Motor Executive Vice President (EVP) and Representative Director, emphasized the company’s concrete plans to execute qualitative business growth and enhance brand value.

July 2016 Production Update

Mazda Motor has also released its July 2016 production update earlier this week.

For the month, Domestic Production of Passenger Vehicles had declined 8.30% year-over-year to 82,331 units; and Overseas Production of Passenger Vehicles had declined 0.30% year-over-year to 46,675 units. Consequently, Global Production of Passenger Vehicles had declined 5.60% year-over-year to 129,006 units. In terms of Commercial Vehicles, Domestic Production had slipped 45.30% year-over-year to 730 units; and Overseas Production had slipped 12.20% year-over-year to 2,908 units Consequently, Global Production had slipped 26.30% year-over-year to 3,638 units.

Year-to-date (YTD) and in terms of Passenger Vehicles, Domestic Production had surged 1.30% year-over-year to 552,048 units; and Overseas Production had surged 3.10% year-over-year to 310,771 units. As a result, Global Production of Passenger Vehicles year-to-date had surged 1.90% year-over-year to 862,819 units. Meanwhile, in terms of Commercial Vehicles, Domestic Production had decreased 40% year-over-year to 5,594 units; and Overseas Production had decreased 19.50% year-over-year to 21,193 units. As a result, Global Production of Commercial Vehicles year-to-date is down by 24.90% year-over-year to 26,787 units

Progressive Care Inc (OTCMKTS:RXMD) Receives Building Permits in North Miami Beach

Progressive Care Inc (OTCMKTS:RXMD) through its subsidiary PharmCo LLC has received building permits in the City of North Miami Beach. With the permits, the health care service provider can now go forth and begin the construction on the warehouse expansion space.

Progressive care has already confirmed that construction on the site is to begin on September 1, 2016, and should take between six and eight weeks for completion. ScriptPro Pharmacy Automation System is to be installed once construction is completed, which should allow the company to ramp up care sales in the city.

Separately, Progressive Care Inc (OTCMKTS:RXMD) has confirmed that its subsidiary PharmCo has begun offering emergency prescription services in some of the areas affected by floods in Louisiana. The subsidiary has teamed up with Express Script as well as the Federal Department of health and Human Services for the noble course.